Cargando…
Targeting DNA Replication and Repair for the Development of Novel Therapeutics against Tuberculosis
Mycobacterium tuberculosis is the etiological agent of tuberculosis (TB), an infectious disease which results in approximately 10 million incident cases and 1.4 million deaths globally each year, making it the leading cause of mortality from infection. An effective frontline combination chemotherapy...
Autores principales: | Reiche, Michael A., Warner, Digby F., Mizrahi, Valerie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5694481/ https://www.ncbi.nlm.nih.gov/pubmed/29184888 http://dx.doi.org/10.3389/fmolb.2017.00075 |
Ejemplares similares
-
Editorial: The DNA Replication Machinery as Therapeutic Targets
por: Gardner, Andrew F., et al.
Publicado: (2019) -
Editorial: Cancer Therapeutics: Targeting DNA Repair Pathways
por: Suraweera, Amila, et al.
Publicado: (2022) -
Mechanisms and Regulation of DNA-Protein Crosslink Repair During DNA Replication by SPRTN Protease
por: Perry, Megan, et al.
Publicado: (2022) -
DNA Sliding Clamps as Therapeutic Targets
por: Altieri, Amanda S., et al.
Publicado: (2018) -
Decoding Cancer Variants of Unknown Significance for Helicase–Nuclease–RPA Complexes Orchestrating DNA Repair During Transcription and Replication
por: Tsutakawa, Susan E., et al.
Publicado: (2021)